Oxandrolone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00621 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 90 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | breast fibrocystic disease | KG + DL |
| 2 | pituitary hormone defiency from vascular origin | KG + DL |
| 3 | hypogonadotropic hypogonadism-frontoparietal alopecia syndrome | KG + DL |
| 4 | non-acquired combined pituitary hormone deficiencies without extra-pituitary malformations | KG + DL |
| 5 | short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia | KG + DL |
| 6 | isolated growth hormone deficiency | KG + DL |
| 7 | short stature due to growth hormone qualitative anomaly | KG + DL |
| 8 | apocrine adenosis of breast | KG + DL |
| 9 | blunt duct adenosis of breast | KG + DL |
| 10 | benign mammary dysplasia | KG + DL |
| 11 | hypogonadotropic hypogonadism with or without anosmia | KG + DL |
| 12 | midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis | KG + DL |
| 13 | fat necrosis of breast | KG + DL |
| 14 | breast abscess | KG + DL |
| 15 | X-linked intellectual disability with isolated growth hormone deficiency | KG + DL |
| 16 | Leydig cell hypoplasia due to LH resistance | KG + DL |
| 17 | 46,XY disorder of sex development due to impaired androgen production | KG + DL |
| 18 | B cell linker protein deficiency | KG + DL |
| 19 | lactation disease | KG + DL |
| 20 | Good syndrome | KG + DL |
| 21 | late-onset isolated ACTH deficiency | KG + DL |
| 22 | non-acquired combined pituitary hormone deficiency | KG + DL |
| 23 | combined pituitary hormone deficiencies, genetic form | KG + DL |
| 24 | breast adenosis | KG + DL |
| 25 | pituitary hormone deficiency secondary to a granulomatous disease | KG + DL |
| 26 | pituitary hormone deficiency from meningeal origin | KG + DL |
| 27 | iatrogenic or traumatic pituitary deficiency | KG + DL |
| 28 | pituitary deficiency | KG + DL |
| 29 | hypopituitarism | KG + DL |
| 30 | amenorrhea (disease) | KG + DL |
| 31 | congenital hypogonadotropic hypogonadism | KG + DL |
| 32 | disease associated with non-acquired combined pituitary hormone deficiency | KG + DL |
| 33 | pituitary hormone deficiency from tumoral origin | KG + DL |
| 34 | hypertrophy of breast | KG + DL |
| 35 | Kallmann syndrome | KG + DL |
| 36 | Sheehan syndrome | KG + DL |
| 37 | primary avascular | KG + DL |
| 38 | gynecomastia | KG + DL |
| 39 | non-acquired pituitary hormone deficiency | KG + DL |
| 40 | eunuchism | KG + DL |
| 41 | aromatase deficiency | KG + DL |
| 42 | tetragametic chimerism | KG + DL |
| 43 | infant gynecomastia | KG + DL |
| 44 | Kaplowitz-Bodurtha syndrome | KG + DL |
| 45 | arthrogryposis epileptic seizures migrational brain disorder | KG + DL |
| 46 | penile/testicular agenesis | KG + DL |
| 47 | familial cystic renal disease | KG + DL |
| 48 | potassium-aggravated myotonia | KG + DL |
| 49 | obesity due to congenital leptin resistance | KG + DL |
| 50 | testicular regression syndrome | KG + DL |
(Showing top 50 of 90 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.